Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.71
CTRX's Cash to Debt is ranked higher than
67% of the 52 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.63 vs. CTRX: 0.71 )
CTRX' s 10-Year Cash to Debt Range
Min: 0.29   Max: No Debt
Current: 0.71

Equity to Asset 0.57
CTRX's Equity to Asset is ranked higher than
87% of the 54 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. CTRX: 0.57 )
CTRX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.85
Current: 0.57

0.3
0.85
F-Score: 7
Z-Score: 4.61
M-Score: -2.18
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 2.64
CTRX's Operating margin (%) is ranked higher than
73% of the 55 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.47 vs. CTRX: 2.64 )
CTRX' s 10-Year Operating margin (%) Range
Min: -32.17   Max: 19.04
Current: 2.64

-32.17
19.04
Net-margin (%) 1.47
CTRX's Net-margin (%) is ranked higher than
73% of the 55 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.36 vs. CTRX: 1.47 )
CTRX' s 10-Year Net-margin (%) Range
Min: -41.12   Max: 16.86
Current: 1.47

-41.12
16.86
ROE (%) 6.32
CTRX's ROE (%) is ranked higher than
69% of the 52 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.53 vs. CTRX: 6.32 )
CTRX' s 10-Year ROE (%) Range
Min: -128.72   Max: 22.93
Current: 6.32

-128.72
22.93
ROA (%) 3.60
CTRX's ROA (%) is ranked higher than
75% of the 55 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.90 vs. CTRX: 3.60 )
CTRX' s 10-Year ROA (%) Range
Min: -43.46   Max: 12.8
Current: 3.6

-43.46
12.8
ROC (Joel Greenblatt) (%) 228.68
CTRX's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 53 Companies
in the Global Health Care Plans industry.

( Industry Median: 118.65 vs. CTRX: 228.68 )
CTRX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -131.7   Max: 665.61
Current: 228.68

-131.7
665.61
Revenue Growth (3Y)(%) 43.60
CTRX's Revenue Growth (3Y)(%) is ranked higher than
96% of the 51 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. CTRX: 43.60 )
CTRX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -12.5   Max: 143.3
Current: 43.6

-12.5
143.3
EBITDA Growth (3Y)(%) 51.60
CTRX's EBITDA Growth (3Y)(%) is ranked higher than
98% of the 46 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CTRX: 51.60 )
CTRX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 56.8
Current: 51.6

0
56.8
EPS Growth (3Y)(%) 33.20
CTRX's EPS Growth (3Y)(%) is ranked higher than
91% of the 46 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.30 vs. CTRX: 33.20 )
CTRX' s 10-Year EPS Growth (3Y)(%) Range
Min: -9.4   Max: 55.8
Current: 33.2

-9.4
55.8
» CTRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

CTRX Guru Trades in Q2 2014

Jim Simons 399,770 sh (New)
Wallace Weitz 748,620 sh (New)
Diamond Hill Capital 406,774 sh (+164.24%)
Manning & Napier Advisors, Inc 4,822,470 sh (+145.55%)
Paul Tudor Jones 15,662 sh (+133.20%)
Joel Greenblatt 12,535 sh (+29.71%)
Vanguard Health Care Fund 4,221,183 sh (unchged)
Louis Moore Bacon 150,000 sh (unchged)
Steven Cohen 310,700 sh (unchged)
Louis Moore Bacon Sold Out
Lee Ainslie Sold Out
Pioneer Investments 377,881 sh (-10.72%)
» More
Q3 2014

CTRX Guru Trades in Q3 2014

Jeremy Grantham 1,654,004 sh (New)
Wallace Weitz 1,001,377 sh (+33.76%)
Diamond Hill Capital 476,976 sh (+17.26%)
Manning & Napier Advisors, Inc 5,328,220 sh (+10.49%)
Vanguard Health Care Fund 4,221,183 sh (unchged)
Pioneer Investments 333,535 sh (unchged)
Joel Greenblatt Sold Out
Steven Cohen 270,400 sh (-12.97%)
Paul Tudor Jones 12,455 sh (-20.48%)
Jim Simons 66,600 sh (-83.34%)
» More
Q4 2014

CTRX Guru Trades in Q4 2014

Joel Greenblatt 22,426 sh (New)
Jim Simons 208,970 sh (+213.77%)
Jeremy Grantham 3,028,803 sh (+83.12%)
Paul Tudor Jones 17,792 sh (+42.85%)
Manning & Napier Advisors, Inc 7,315,426 sh (+37.30%)
Vanguard Health Care Fund 4,937,683 sh (+16.97%)
Wallace Weitz 1,162,989 sh (+16.14%)
Pioneer Investments 379,996 sh (+13.93%)
Diamond Hill Capital 505,966 sh (+6.08%)
Steven Cohen Sold Out
» More
Q1 2015

CTRX Guru Trades in Q1 2015

Manning & Napier Advisors, Inc 2,208,429 sh (-69.81%)
» More
» Details

Insider Trades

Latest Guru Trades with CTRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 43.00
CTRX's P/E(ttm) is ranked higher than
58% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 31.90 vs. CTRX: 43.00 )
CTRX' s 10-Year P/E(ttm) Range
Min: 2.84   Max: 78.05
Current: 43

2.84
78.05
Forward P/E 16.56
CTRX's Forward P/E is ranked higher than
83% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.73 vs. CTRX: 16.56 )
N/A
PE(NRI) 42.80
CTRX's PE(NRI) is ranked higher than
75% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 31.90 vs. CTRX: 42.80 )
CTRX' s 10-Year PE(NRI) Range
Min: 2.83   Max: 77.62
Current: 42.8

2.83
77.62
P/B 2.50
CTRX's P/B is ranked higher than
78% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.10 vs. CTRX: 2.50 )
CTRX' s 10-Year P/B Range
Min: 1.58   Max: 8.41
Current: 2.5

1.58
8.41
P/S 0.60
CTRX's P/S is ranked higher than
65% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.69 vs. CTRX: 0.60 )
CTRX' s 10-Year P/S Range
Min: 0.42   Max: 6.67
Current: 0.6

0.42
6.67
PFCF 26.30
CTRX's PFCF is ranked lower than
53% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.63 vs. CTRX: 26.30 )
CTRX' s 10-Year PFCF Range
Min: 10.38   Max: 97.6
Current: 26.3

10.38
97.6
POCF 22.89
CTRX's POCF is ranked higher than
68% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.53 vs. CTRX: 22.89 )
CTRX' s 10-Year POCF Range
Min: 8.78   Max: 87.5
Current: 22.89

8.78
87.5
EV-to-EBIT 24.47
CTRX's EV-to-EBIT is ranked higher than
70% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.70 vs. CTRX: 24.47 )
CTRX' s 10-Year EV-to-EBIT Range
Min: 9.9   Max: 64.6
Current: 24.47

9.9
64.6
PEG 0.97
CTRX's PEG is ranked higher than
97% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.17 vs. CTRX: 0.97 )
CTRX' s 10-Year PEG Range
Min: 0.53   Max: 43.6
Current: 0.97

0.53
43.6
Shiller P/E 78.00
CTRX's Shiller P/E is ranked higher than
53% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 42.84 vs. CTRX: 78.00 )
CTRX' s 10-Year Shiller P/E Range
Min: 7.81   Max: 116.44
Current: 78

7.81
116.44
Current Ratio 1.43
CTRX's Current Ratio is ranked higher than
78% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.30 vs. CTRX: 1.43 )
CTRX' s 10-Year Current Ratio Range
Min: 0.98   Max: 5.67
Current: 1.43

0.98
5.67
Quick Ratio 1.43
CTRX's Quick Ratio is ranked higher than
78% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.77 vs. CTRX: 1.43 )
CTRX' s 10-Year Quick Ratio Range
Min: 0.98   Max: 5.66
Current: 1.43

0.98
5.66
Days Sales Outstanding 21.99
CTRX's Days Sales Outstanding is ranked higher than
78% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 28.82 vs. CTRX: 21.99 )
CTRX' s 10-Year Days Sales Outstanding Range
Min: 17.64   Max: 92.51
Current: 21.99

17.64
92.51

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.80
CTRX's Price/DCF (Projected) is ranked higher than
75% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.40 vs. CTRX: 1.80 )
CTRX' s 10-Year Price/DCF (Projected) Range
Min: 1.08   Max: 3.29
Current: 1.8

1.08
3.29
Price/Median PS Value 0.60
CTRX's Price/Median PS Value is ranked higher than
97% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.30 vs. CTRX: 0.60 )
CTRX' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 4.61
Current: 0.6

0.2
4.61
Price/Peter Lynch Fair Value 1.70
CTRX's Price/Peter Lynch Fair Value is ranked higher than
87% of the 60 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.90 vs. CTRX: 1.70 )
CTRX' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.37   Max: 2.6
Current: 1.7

0.37
2.6
Earnings Yield (Greenblatt) 4.10
CTRX's Earnings Yield (Greenblatt) is ranked higher than
58% of the 55 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.10 vs. CTRX: 4.10 )
CTRX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 10.1
Current: 4.1

1.5
10.1
Forward Rate of Return (Yacktman) 49.06
CTRX's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.27 vs. CTRX: 49.06 )
CTRX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -23.6   Max: 50
Current: 49.06

-23.6
50

Business Description

Industry: Health Care Plans » Health Care Plans
Compare: » details
Traded in other countries:CCT.Canada,
Catamaran Corp is a provider of pharmacy benefit management services PBM and healthcare IT solutions to the healthcare benefit management industry. The Company's PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail service pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis. The Company owns a mail service pharmacy and a specialty service pharmacy ('Ascend'). PBM services such as pharmacy network management could be provided to the company's customers using the Company's own system software and services. It provides on-line transaction processing solutions through web-enabled, real-time transaction processing technology. The Company's informed Rx offering is a suite of a la carte PBM services that provide a flexible and cost-effective alternative to traditional PBM offerings typically employed by health plans, government agencies and employers. It also provides a pharmacy spend management solutions and information technology capabilities. RxCLAIM (r) is an on-line transaction processing system designed to provide instant on-line adjudication of third-party prescription drug claims at the point of service, including trouble-free claims management and cost-effective review, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider and drug details. RxCLAIM is designed to provide the company's customers with automation efficiencies, flexibility and control by facilitating the real-time processing of pharmacy claims and payments against eligibility, plan benefits, formularies, price, drug utilization review, prior authorization and rebates in addition to many other features. It is also a provider of HCIT solutions and services to providers, payers and other participants in the pharmaceutical supply chain in North America. SXC's product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's solutions are available on a license basis with on-going maintenance and support or on a transaction fee basis using an ASP model. The Company's provider customers include independent, regional chain, institutional, and mail-order pharmacies. It is subject to state and federal statutes and regulations governing the operation of mail service pharmacies and the dispensing of controlled substances.
» More Articles for CTRX

Headlines

Articles On GuruFocus.com
UnitedHealth Group Is Ready For A Huge Pharmacy Deal Apr 06 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
UnitedHealth Planning Catamaran Corp’s Acquisition For $12.78 Billion Apr 02 2015 
Gilead Sciences Offering Fresh Wave Of Competition To AbbVie’s Viekira Pak Feb 06 2015 
Wallace Weitz's Partners Value Fund Q2 Commentary Oct 06 2014 
Wallace Weitz's Value Fund Q2 Commentary Oct 06 2014 
Catamaran: A Safe investment for the Future Apr 24 2014 
Stocks Near Their 52-Week Low (Part 1) Apr 04 2014 
Stocks for 2014 - Something for Everyone: Part 1 Jan 10 2014 
52-Week High Companies: TD Ameritrade Holding Corporation, Catamaran Corp., Pentair Ltd., Seadrill L Aug 04 2013 

More From Our Partners
Stock Market News for April 06, 2015 - Market News Apr 6 2015 - ZACKS

More From Other Websites
Catamaran to Release 2015 First Quarter Results on April 30, 2015 Apr 23 2015
Catamaran to Release 2015 First Quarter Results on April 30, 2015 Apr 23 2015
Catamaran downgraded by Maxim Group Apr 22 2015
Catamaran's SECURE Generates More Than 70-Percent Reduction in Compound Medication Spend Apr 21 2015
Catamaran's SECURE Generates More Than 70-Percent Reduction in Compound Medication Spend Apr 21 2015
Why Walgreens Won't Buy A PBM Anytime Soon Apr 18 2015
UnitedHealth hikes forecast, shares edge to new heights Apr 16 2015
UnitedHealth hikes forecast, shares edge to new heights Apr 16 2015
UnitedHealth hits all the notes, shares head for new heights Apr 16 2015
UnitedHealth hits all the notes, shares head for new heights Apr 16 2015
UnitedHealth Boosts Forecast as Quarterly Profit Beats Estimates Apr 16 2015
UnitedHealth leads Dow gainers after analyst upgrade Apr 13 2015
UnitedHealth Eyes Biggest Earnings Gain In Years Apr 13 2015
Brazos Private Equity Partners Completes Sale of Healthcare Solutions To Catamaran Corporation Apr 09 2015
Catamaran Completes Acquisition of Healthcare Solutions, Inc. Apr 09 2015
Catamaran Completes Acquisition of Healthcare Solutions, Inc. Apr 09 2015
Jefferies Downgrades Catamaran Amid News That Competing Bids For Company Are Unlikely Apr 07 2015
Will UnitedHealth (UNH) Stock be Affected Today by Investor Suit to Block Catamaran Deal? Apr 07 2015
Law Offices of Marc S. Henzel Announces Securities Class Action Periods Apr 07 2015
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran... Apr 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK